# STERRX, LLC: Form D filings

STERRX, LLC, a pharmaceuticals company in Plattsburgh, NY, filed 2 Form D notices with the SEC between 2016 and 2017. The latest, on September 21, 2017, reports $15 million sold of a $15 million offering to 1 investor.

Find out what STERRX, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20STERRX%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=STERRX%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fsterrx-llc-1670452)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20STERRX%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=STERRX%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fsterrx-llc-1670452)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 141 IDAHO AVE, Plattsburgh, NY, 12903
- Phone: (518) 324-7879
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: New York
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1670452

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 21, 2017 | New notice | $15,000,000 | $15,000,000 | $0 | 1 | Sep 8, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1670452/000167045217000002/0001670452-17-000002-index.htm) |
| Mar 30, 2016 | New notice | $3,000,000 | $3,000,000 | $0 | 2 | Mar 11, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1670452/000167045216000002/0001670452-16-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Carl L Martin | Director |  |
| Kent L Smeltz | Director |  |
| Jeff L LaBombard | Director |  |
| Vera L Delorme | Executive Officer |  |
| Tana L Hanley | Director |  |
| Gary L Hanley | Executive Officer, Director |  |
| Sandra L Hawkins | Director |  |
| Terry L Wiley | Executive Officer, Director |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Sep 18, 2017](https://specstream.ai/data/form-d/week/2017-09-18) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what STERRX, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).